NexImmune (STU:7370) FFO


STU:7370 NexImmune Inc STU:7370
33 GF Score
Price €4.55
View Full Analysis

What is NexImmune FFO?

FFO (Funds from operations) only applies to REITs.

STU:7370
33GF Score
NexImmune Inc STU:7370
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NexImmune Business Description

Address 9119 Gaither Road, Gaithersburg, MD, USA, 20877
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
33GF Score

Get the complete analysis for STU:7370

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.55
Price